Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

American Medical Systems Announces 2:1 Stock Split; Company Reports Preliminary Record Sales of $60 Million in Fourth Quarter.


MINNEAPOLIS -- American Medical Systems Holdings, Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:AMMD AMMD Aerodynamic Mass Median Diameter ) announced today that its Board of Directors has approved a two-for-one split of the company's common stock in the form of a 100% percent stock dividend. The stock split is subject to shareholder approval of an increase in the number of authorized shares Authorized shares

Number of shares authorized for issuance by a firm's corporate charter.
 of common stock from 75 million to 200 million. American Medical Systems plans to hold a special meeting of stockholders on March 3, 2005 to approve the increase. If the stockholders approve the increase, all stockholders of record on March 14, 2005 will receive one additional share for each share then held. Distribution of shares is scheduled to be made on or about March 21, 2005.

American Medical Systems also reported preliminary record sales of $60 million for the fourth quarter of 2004, a 27 percent increase over sales of $47.2 million in the comparable quarter of 2003. Preliminary sales in the full year 2004 were $208.8 million, up 24 percent from sales of $168.3 million in 2003. The Company anticipates full year earnings, excluding any one-time items, to be in line with the previously guided range of $0.99 to $1.01 per share.

Martin J. Emerson, President and recently named CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of American Medical Systems, noted, "We are pleased that the sales momentum of the first three quarters of 2004 was sustained through the fourth quarter. In addition to strong core business growth, sales from our recent TherMatrx acquisition also met our expectations. I look forward to the challenge of continuing the company's strong record of growth in 2005 and beyond."

Douglas W. Kohrs, Chairman of American Medical Systems, commented, "The decision to split the company's stock represents a vote of confidence by our Board of Directors and, along with our financial performance, evidences our success during the past five years in transforming AMS AMS - Andrew Message System  from essentially a two- product company to a leader in providing an array of solutions for the pelvic health needs of men and women."

About American Medical Systems

American Medical Systems, headquartered in Minnetonka, Minnesota is a diversified supplier of medical devices and procedures to cure erectile dysfunction Erectile Dysfunction Definition

Erectile dysfunction (ED), formerly known as impotence, is the inability to achieve or maintain an erection long enough to engage in sexual intercourse.
, benign prostatic hyperplasia benign prostatic hyperplasia
n. Abbr. BPH
A nonmalignant enlargement of the prostate gland commonly occurring in men after the age of 50, and sometimes leading to compression of the urethra and obstruction of the flow of urine.
, incontinence, and other pelvic disorders in men and women. Although not life threatening, these disorders can significantly diminish one's quality of life and profoundly affect social relation-ships. In recent years, the number of people seeking treatment has increased markedly as a result of longer lives, higher quality-of-life expectations and greater awareness of new treatment alternatives. American Medical Systems' products reduce or eliminate the incapacitating in·ca·pac·i·tate  
tr.v. in·ca·pac·i·tat·ed, in·ca·pac·i·tat·ing, in·ca·pac·i·tates
1. To deprive of strength or ability; disable.

2. To make legally ineligible; disqualify.
 effects of these diseases, often through minimally invasive therapies. The Company's products were used to treat over 120,000 patients in 54 countries during the last year.

More information about the company and its products can be found at its website www.AmericanMedicalSystems.com and in the company's Annual Report on Form 10-K Form 10-K

A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information.


Form 10-K

See 10-K.
 for 2003 and its other SEC filings.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jan 10, 2005
Words:485
Previous Article:ScanSoft Speech Technology Drives CULLMANN's Universal Hands-free Kit for Mobile Phones.
Next Article:Unpolished. Unkempt. Unleashed. Undercover. ``Miss Congeniality'' Deluxe Edition DVD Debuts March 15 from Warner Home Video.
Topics:



Related Articles
Respironics reports record fourth-quarter and year end results.
Cohesion Technologies Reports Second Quarter Results.
Guidant Takes Fourth Quarter 1998 Charge Associated with Origin Subsidiary.
SplitTrader.com Announces Investment Opinion on CYTYC Corporation.
Biomet Announces Cash Dividend, Three-For-Two Stock Split, and Record Fiscal Year End Results.
ALARIS Medical Systems Sees 15% Fourth Quarter 2003 Sales Increase; Fourth Quarter Earnings Expected to Exceed Expectations; Company Raises Guidance...
St. Jude Medical Reports Third Quarter Results.
American Medical Systems Exceeds Revenue Expectations with 22 Percent Growth in Fourth Quarter 2005; Revenue Tops $73 Million on Strength in Male...
American Medical Systems Reports 20 Percent Second Quarter Revenue Growth; Record Revenues of $79 Million Exceed Expectations for Quarterly...
ZOLL Medical Corporation Announces Second Quarter Results.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles